In search of more opportunities, I followed a YMB spammer from GNBT to HEB.

American Bulls had a favorable reading on the candlestick analysis, so I bought in at $3.02 on Mar. 13, 2006.

This is primarily a bird flu play; avian flu is hot at the moment, and the biopharms that look like they can contribute to a vaccine are ready to shoot up. This marketwatch story at Yahoo said in part:

In a recent interview, Hemispherx chief executive officer Dr. William Carter said Ampligen can greatly boost the effectiveness of Roche's Tamiflu and GlaxoSmithKline's Relenza, two leading anti-virals that governments have been rushing to stockpile as a hedge against the deadly illness. The drug also shows promise in strengthening the power of various avian flu vaccines currently under development. By bolstering the drugs' effectiveness, he said, doctors would also be able to greatly stretch the supply of the medicines.

Bought a little more (in an IRA this time) at $3.65 on 3/20/06.

Another opinion

Interesting post on GNBT, HEB, and NVAX (I'm in all three).